The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 361:1396-1398 October 1, 2009 Number 14
NextNext

Gestational Diabetes — Whom Do We Treat?
David A. Sacks, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Landon, M. B.
-PubMed Citation
In 1964, O'Sullivan and Mahan1 proposed glucose-tolerance-test criteria to define gestational diabetes mellitus — that is, any degree of glucose intolerance that first occurs or is first identified during pregnancy. Women whose glucose levels exceeded these thresholds during an index pregnancy were recognized to be at increased risk for developing nongestational diabetes 8 years later. Subsequently, considerable data indicated that lowering glucose levels in women who were diagnosed with gestational diabetes mellitus was associated with reduced rates of perinatal complications and death. However, many considered these data to be insufficient evidence to support treatment for gestational diabetes2,3; most of . . . [Full Text of this Article]


Source Information

From the Department of Obstetrics and Gynecology, Kaiser Foundation Hospital, Bellflower, CA.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.